Phase 3 CLL/SLL trial of ICP-248 plus orelabrutinib doses first patient
The first patient has been dosed in a Phase…
Blood cancer is a broad term encompassing diseases in which blood cells grow too much or develop abnormally. Typically, blood cancers are classified into three main categories – leukemia, lymphoma, and myeloma – but they can be further divided into dozens of specific types, each with unique features.
Read moreA wide range of therapies are available for treating blood cancer, from chemotherapy and targeted therapy to radiation, stem cell transplant, and surgery. When devising a suitable treatment plan for blood cancer, healthcare providers take into account various factors, such as age, overall health, the specific type of blood cancer, and potential treatment side effects.
Read moreThe first patient has been dosed in a Phase…
Orca-T, Orca Bio‘s investigational allogeneic stem cell transplant…
Chromoanagenesis — an abnormal rearrangement of DNA within the…
China has granted breakthrough therapy designation to olverembatinib to…
Aptose Biosciences will be testing a higher…
A triple-combination therapy using tuspetinib, Aptose Biosciences‘…